Telesis Bio Inc. (TBIO) NASDAQ

$4.51 (0.11) (-2.43%)

Market Cap: $7.78M

As of 05/16/24 11:45 AM EDT. Market open.

(TBIO)

Telesis Bio Inc. (TBIO)
NASDAQ

$4.51
(0.11) (-2.43%)

Market Cap: $7.78M

As of 05/16/24 11:45 AM EDT. Market open.

Add to Portfolio

sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full Time Employees
76
Address
.
PRICE CHART FOR TELESIS BIO INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.50
Previous Close
$4.62
Days Range
$4.16 - $4.69
52 week range
$3.96 - $43.02
Volume
8,038
Avg. Volume (30 days)
25,182
Market Cap
$7.78M
Dividend Yield
-
P/E
(0.16)
Shares Outstanding
1,682,794
Open
$4.50
Previous Close
$4.62
Days Range
$4.16 - $4.69
52 week range
$3.96 - $43.02
Volume
8,038
Avg. Volume (30 days)
25,182
Market Cap
$7.78M
Dividend Yield
-
P/E
(0.16)
Shares Outstanding
1,682,794
FINANCIAL STATEMENTS FOR TELESIS BIO INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TELESIS BIO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Nelson Todd RobertChief Executive OfficerMar 01, 2024 Option Exercise$0.534,7562,511174,240Mar 05, 2024, 06:55 PM
Esser Eric EugenePresident & COOMar 01, 2024 Option Exercise$0.533,3401,76429,260Mar 05, 2024, 06:40 PM
Gibson Daniel GlennChief Technology OfficerMar 01, 2024 Option Exercise$0.53656346105,562Mar 05, 2024, 06:07 PM
Cutler RobChief Legal OfficerMar 01, 2024 Option Exercise$0.531,37672735,718Mar 05, 2024, 06:04 PM
Nelson Todd RobertPresident & CEOFeb 27, 2024 Option Exercise$0.534,7762,550131,296Feb 29, 2024, 08:15 PM
Gibson Daniel GlennChief Technology OfficerFeb 27, 2024 Option Exercise$0.532,2651,21099,818Feb 29, 2024, 08:10 PM
Cutler RobChief Legal OfficerFeb 27, 2024 Option Exercise$0.532,1741,16123,294Feb 29, 2024, 08:05 PM
Nelson Todd RobertPresident & CEOMay 04, 2023 Sale$2.832,5757,277136,072May 08, 2023, 08:11 PM
Gibson Daniel GlennChief Technology OfficerMay 04, 2023 Sale$2.831,1903,363102,083May 08, 2023, 08:09 PM
Cutler RobChief Legal OfficerMay 04, 2023 Sale$2.831,1743,31825,468May 08, 2023, 08:06 PM
Nelson Todd RobertPresident & CEONov 11, 2022 Buy$1.56122,516191,542122,516Nov 14, 2022, 04:44 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Nelson Todd RobertChief Executive Officer03/01/20242,511
Esser Eric EugenePresident & COO03/01/20241,764
Gibson Daniel GlennChief Technology Officer03/01/2024346
Cutler RobChief Legal Officer03/01/2024727
Nelson Todd RobertPresident & CEO02/27/20242,550
Gibson Daniel GlennChief Technology Officer02/27/20241,210
Cutler RobChief Legal Officer02/27/20241,161
Nelson Todd RobertPresident & CEO05/04/20237,277
Gibson Daniel GlennChief Technology Officer05/04/20233,363
Cutler RobChief Legal Officer05/04/20233,318
Nelson Todd RobertPresident & CEO11/11/2022191,542
Load More Insider Transactions
FUNDS WITH A POSITION IN TELESIS BIO INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC83,5610%No changeOther
RENAISSANCE TECHNOLOGIES LLC27,5470.00002%ExitedOther
BLACKROCK INC.24,8300%-3.97%Other
CHANGE IN SHARES OUTSTANDING FOR TELESIS BIO INC
STOCK BUYBACKS FOR TELESIS BIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
06/30/2021
-80.79%
11Q
03/31/2024
03/31/2021
-67.82%
12Q
03/31/2024
12/31/2020
-66.61%
13Q
03/31/2024
09/30/2020
-66.59%
14Q
03/31/2024
06/30/2020
-66.58%
15Q
03/31/2024
03/31/2020
-66.58%
16Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
-80.79%
11Q
03/31/2021
-67.82%
12Q
12/31/2020
-66.61%
13Q
09/30/2020
-66.59%
14Q
06/30/2020
-66.58%
15Q
03/31/2020
-66.58%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR TELESIS BIO INC
LOADING...